Calcium release channel deficiency syndrome in patients diagnosed with idiopathic ventricular fibrillation and decedents classified as sudden unexplained death in the young. [PDF]
EuropaceGiammarino L +7 more
europepmc +1 more source
The Cardiac Sodium Channel Safety Profile of Cenobamate at Therapeutic Concentrations: In Vitro Analyses. [PDF]
Clin Transl SciCrumb WJ, Melnick SM, Glenn KJ.
europepmc +1 more source
Exercise induced irregular wide QRS tachycardia with right bundle branch block morphology and extreme QRS axis deviation. [PDF]
Indian Pacing Electrophysiol JKalfon E, Or T, Belhassen B.
europepmc +1 more source
Flecainide Toxicity Leading to Transient Heart Failure With Reduced Ejection Fraction: A Case Study. [PDF]
CureusWolchover T +3 more
europepmc +1 more source
Case series of Type 1 Brugada pattern provoked by exercise: a role for diagnostic treadmill stress testing. [PDF]
Eur Heart J Case RepMehta OH +7 more
europepmc +1 more source
Diabetes Mellitus Reduces the Antiarrhythmic Effect of Ion Channel Blockers [PDF]
イトウ, イサオ, 伊藤, 勲
core
Fetal Supraventricular Tachycardia: What Do We Know up to This Day? [PDF]
J Pers MedTsokkou S +9 more
europepmc +1 more source
Related searches:
Flecainide. Flecainide is a Class IC antiarrhythmic agent whose primary electrophysiologic effect is a slowing of conduction in a wide range of cardiac tissues. It is well absorbed and effective in suppressing isolated premature ventricular contractions (PVCs) or nonsustained ventricular arrhythmia but has only a modest efficacy when electrophysiologic
R H, Falk, R I, Fogel
openaire +3 more sources